HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Møller Selected Research

Glucose (Dextrose)

11/2023The effects of postprandial exercise and meal glycemic index on plasma glucose and glucoregulatory hormone responses after Roux-en-Y gastric bypass.
1/2023Postprandial dysfunction in fatty liver disease.
10/2022Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Møller Research Topics

Disease

2Non-alcoholic Fatty Liver Disease
01/2023 - 01/2023
1Hypoglycemia (Reactive Hypoglycemia)
11/2023
1Fibrosis (Cirrhosis)
01/2023
1Type 2 Diabetes Mellitus (MODY)
10/2022
1Heart Failure
10/2022

Drug/Important Bio-Agent (IBA)

3Glucose (Dextrose)FDA LinkGeneric
11/2023 - 10/2022
2Glucagon (Glukagon)FDA Link
01/2023 - 01/2023
1Hormones (Hormone)IBA
11/2023
1Glucagon Receptors (Glucagon Receptor)IBA
01/2023
1fibroblast growth factor 21IBA
01/2023
1C-PeptideIBA
01/2023
1Neprilysin (Neutral Endopeptidase)IBA
10/2022
1sacubitril and valsartan sodium hydrate drug combinationIBA
10/2022
1Glucagon-Like Peptide 1 (GLP 1)IBA
10/2022
1Angiotensin Receptor AntagonistsIBA
10/2022
1Pancreatic HormonesIBA
10/2022

Therapy/Procedure

1Gastric Bypass (Roux-en-Y Gastric Bypass)
11/2023